The effect of anti-coagulation dosage on the outcome of hospitalized COVID-19 patients in Ethiopia: a multi-center retrospective cohort study

Table 4 Cox regression analysis for length of hospital stay

Covariates	Severe		Covariates	Critical
Covariates	Adjusted HR (95% CI)	p-value	Covariates	HR (95% CI)	p-value
Anticoagulation dosage	0.76 (0.59 – 0.98)	0.033	Anticoagulation dosage	0.61 (0.36 – 1.04)	0.069
Age	0.99 (0.98 – 1.00)	0.047
Gender (male sex)	1.21 (0.93 – 1.58)	0.151
Stroke	0.32 (0.12 – 0.88)	0.027

Left: subgroup analysis for severe patients, Right: subgroup analysis for critical patients. (Variables with p < 0.25 in univariate analysis are included)

ISSN: 1471-2466